Relationship between serum insulin-like growth factor-1, IGF binding protein-3 levels and body height before and after gonadotropin-releasing hormone agonist therapy
PurposeThe gonadotropin-releasing hormone agonist (GnRHa) is widely used to treat patients with precocious puberty. However, its effect on growth is often difficult to predict because of the diverse nature of its causes and presentation. This study aims to show the impact of GnRHa treatment on insul...
Saved in:
Main Authors: | Han Sol Song (Author), Won Bok Choi (Author), Joon Sup Song (Author), Il Tae Hwang (Author), Seung Yang (Author) |
---|---|
Format: | Book |
Published: |
Korean Society of Pediatric Endocrinology,
2014-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone
by: Mo Kyung Jung, et al.
Published: (2014) -
Influence of The -202 A/C insulin-like growth factor-binding protein-3 promoter polymorphism on individual variation in height in Korean girls
by: Min Ju Yi, et al.
Published: (2017) -
Effect of gonadotropin-releasing hormone agonist treatment on near final height in girls with central precocious puberty and early puberty
by: Eun Hye Yang, et al.
Published: (2023) -
Age of menarche and near adult height after long-term gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty
by: Joon-Woo Baek, et al.
Published: (2014) -
Effects of gonadotropin-releasing hormone agonist treatment on final adult height in boys with idiopathic central precocious puberty
by: Ah Young Cho, et al.
Published: (2021)